These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Arylamine N-acetyltransferases: structural and functional implications of polymorphisms. Sim E; Lack N; Wang CJ; Long H; Westwood I; Fullam E; Kawamura A Toxicology; 2008 Dec; 254(3):170-83. PubMed ID: 18852012 [TBL] [Abstract][Full Text] [Related]
24. Generation and functional characterization of arylamine N-acetyltransferase Nat1/Nat2 double-knockout mice. Sugamori KS; Wong S; Gaedigk A; Yu V; Abramovici H; Rozmahel R; Grant DM Mol Pharmacol; 2003 Jul; 64(1):170-9. PubMed ID: 12815173 [TBL] [Abstract][Full Text] [Related]
25. The role of N-acetylation polymorphisms in smoking-associated bladder cancer: evidence of a gene-gene-exposure three-way interaction. Taylor JA; Umbach DM; Stephens E; Castranio T; Paulson D; Robertson C; Mohler JL; Bell DA Cancer Res; 1998 Aug; 58(16):3603-10. PubMed ID: 9721868 [TBL] [Abstract][Full Text] [Related]
26. N-Acetyltransferase-2 genetic polymorphism, well-done meat intake, and breast cancer risk among postmenopausal women. Deitz AC; Zheng W; Leff MA; Gross M; Wen WQ; Doll MA; Xiao GH; Folsom AR; Hein DW Cancer Epidemiol Biomarkers Prev; 2000 Sep; 9(9):905-10. PubMed ID: 11008907 [TBL] [Abstract][Full Text] [Related]
27. Polymorphic NATs and cancer predisposition. Hirvonen A IARC Sci Publ; 1999; (148):251-70. PubMed ID: 10493262 [TBL] [Abstract][Full Text] [Related]
28. Genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2) and risk of non-Hodgkin lymphoma. Morton LM; Schenk M; Hein DW; Davis S; Zahm SH; Cozen W; Cerhan JR; Hartge P; Welch R; Chanock SJ; Rothman N; Wang SS Pharmacogenet Genomics; 2006 Aug; 16(8):537-45. PubMed ID: 16847422 [TBL] [Abstract][Full Text] [Related]
29. N-acetyltransferase 2 genetic polymorphism: effects of carcinogen and haplotype on urinary bladder cancer risk. Hein DW Oncogene; 2006 Mar; 25(11):1649-58. PubMed ID: 16550165 [TBL] [Abstract][Full Text] [Related]
30. Role of the human N-acetyltransferase 2 genetic polymorphism in metabolism and genotoxicity of 4, 4'-methylenedianiline. Salazar-González RA; Zhang X; Doll MA; Lykoudi A; Hein DW Arch Toxicol; 2019 Aug; 93(8):2237-2246. PubMed ID: 31292670 [TBL] [Abstract][Full Text] [Related]
31. Genetic polymorphism in N-Acetyltransferase (NAT): Population distribution of NAT1 and NAT2 activity. Walker K; Ginsberg G; Hattis D; Johns DO; Guyton KZ; Sonawane B J Toxicol Environ Health B Crit Rev; 2009; 12(5-6):440-72. PubMed ID: 20183529 [TBL] [Abstract][Full Text] [Related]
32. Metabolic activation of aromatic and heterocyclic N-hydroxyarylamines by wild-type and mutant recombinant human NAT1 and NAT2 acetyltransferases. Hein DW; Rustan TD; Ferguson RJ; Doll MA; Gray K Arch Toxicol; 1994; 68(2):129-33. PubMed ID: 8179482 [TBL] [Abstract][Full Text] [Related]
33. Catalytic properties and heat stabilities of novel recombinant human N-acetyltransferase 2 allozymes support existence of genetic heterogeneity within the slow acetylator phenotype. Hein DW; Doll MA Arch Toxicol; 2017 Aug; 91(8):2827-2835. PubMed ID: 28523442 [TBL] [Abstract][Full Text] [Related]
34. Arylamine N-acetyltransferase polymorphisms in Han Chinese patients with ankylosing spondylitis and their correlation to the adverse drug reactions to sulfasalazine. Hou ZD; Xiao ZY; Gong Y; Zhang YP; Zeng QY BMC Pharmacol Toxicol; 2014 Nov; 15():64. PubMed ID: 25413361 [TBL] [Abstract][Full Text] [Related]
35. Para-phenylenediamine and allergic sensitization: risk modification by N-acetyltransferase 1 and 2 genotypes. Blömeke B; Brans R; Coenraads PJ; Dickel H; Bruckner T; Hein DW; Heesen M; Merk HF; Kawakubo Y Br J Dermatol; 2009 Nov; 161(5):1130-5. PubMed ID: 19663877 [TBL] [Abstract][Full Text] [Related]
36. Human arylamine N-acetyltransferase 2 genotype-dependent protein expression in cryopreserved human hepatocytes. Salazar-González RA; Doll MA; Hein DW Sci Rep; 2020 May; 10(1):7566. PubMed ID: 32372066 [TBL] [Abstract][Full Text] [Related]
37. Role of Human N-Acetyltransferase 2 Genetic Polymorphism on Aromatic Amine Carcinogen-Induced DNA Damage and Mutagenicity in a Chinese Hamster Ovary Cell Mutation Assay. Baldauf KJ; Salazar-González RA; Doll MA; Pierce WM; States JC; Hein DW Environ Mol Mutagen; 2020 Feb; 61(2):235-245. PubMed ID: 31490564 [TBL] [Abstract][Full Text] [Related]
38. A pilot study testing the association between N-acetyltransferases 1 and 2 and risk of oral squamous cell carcinoma in Japanese people. Katoh T; Kaneko S; Boissy R; Watson M; Ikemura K; Bell DA Carcinogenesis; 1998 Oct; 19(10):1803-7. PubMed ID: 9806162 [TBL] [Abstract][Full Text] [Related]
39. Association between polymorphisms at N-acetyltransferase 1 (NAT1) & risk of oral leukoplakia & cancer. Majumder M; Ghosh S; Roy B Indian J Med Res; 2012 Oct; 136(4):605-13. PubMed ID: 23168701 [TBL] [Abstract][Full Text] [Related]